Cancer statistics, 2007
- PMID: 17237035
- DOI: 10.3322/canjclin.57.1.43
Cancer statistics, 2007
Abstract
Each year, the American Cancer Society (ACS) estimates the number of new cancer cases and deaths expected in the United States in the current year and compiles the most recent data on cancer incidence, mortality, and survival based on incidence data from the National Cancer Institute, Centers for Disease Control and Prevention, and the North American Association of Central Cancer Registries and mortality data from the National Center for Health Statistics. This report considers incidence data through 2003 and mortality data through 2004. Incidence and death rates are age-standardized to the 2000 US standard million population. A total of 1,444,920 new cancer cases and 559,650 deaths for cancers are projected to occur in the United States in 2007. Notable trends in cancer incidence and mortality rates include stabilization of the age-standardized, delay-adjusted incidence rates for all cancers combined in men from 1995 through 2003; a continuing increase in the incidence rate by 0.3% per year in women; and a 13.6% total decrease in age-standardized cancer death rates among men and women combined between 1991 and 2004. This report also examines cancer incidence, mortality, and survival by site, sex, race/ethnicity, geographic area, and calendar year, as well as the proportionate contribution of selected sites to the overall trends. While the absolute number of cancer deaths decreased for the second consecutive year in the United States (by more than 3,000 from 2003 to 2004) and much progress has been made in reducing mortality rates and improving survival, cancer still accounts for more deaths than heart disease in persons under age 85 years. Further progress can be accelerated by supporting new discoveries and by applying existing cancer control knowledge across all segments of the population.
Similar articles
-
Cancer statistics, 2010.CA Cancer J Clin. 2010 Sep-Oct;60(5):277-300. doi: 10.3322/caac.20073. Epub 2010 Jul 7. CA Cancer J Clin. 2010. PMID: 20610543
-
Cancer statistics, 2008.CA Cancer J Clin. 2008 Mar-Apr;58(2):71-96. doi: 10.3322/CA.2007.0010. Epub 2008 Feb 20. CA Cancer J Clin. 2008. PMID: 18287387
-
Cancer statistics, 2009.CA Cancer J Clin. 2009 Jul-Aug;59(4):225-49. doi: 10.3322/caac.20006. Epub 2009 May 27. CA Cancer J Clin. 2009. PMID: 19474385
-
Cancer statistics, 2004.CA Cancer J Clin. 2004 Jan-Feb;54(1):8-29. doi: 10.3322/canjclin.54.1.8. CA Cancer J Clin. 2004. PMID: 14974761 Review.
-
Annual report to the nation on the status of cancer, 1975-2000, featuring the uses of surveillance data for cancer prevention and control.J Natl Cancer Inst. 2003 Sep 3;95(17):1276-99. doi: 10.1093/jnci/djg040. J Natl Cancer Inst. 2003. PMID: 12953083 Review.
Cited by
-
Development of 18F-labeled picolinamide probes for PET imaging of malignant melanoma.J Med Chem. 2013 Feb 14;56(3):895-901. doi: 10.1021/jm301740k. Epub 2013 Jan 18. J Med Chem. 2013. PMID: 23301672 Free PMC article.
-
Cytologic Features of ALK-Positive Pulmonary Adenocarcinoma.Korean J Pathol. 2013 Jun;47(3):252-7. doi: 10.4132/KoreanJPathol.2013.47.3.252. Epub 2013 Jun 25. Korean J Pathol. 2013. PMID: 23837018 Free PMC article.
-
A preclinical evaluation of antimycin a as a potential antilung cancer stem cell agent.Evid Based Complement Alternat Med. 2013;2013:910451. doi: 10.1155/2013/910451. Epub 2013 Jun 11. Evid Based Complement Alternat Med. 2013. PMID: 23840269 Free PMC article.
-
IL-8 induces miR-424-5p expression and modulates SOCS2/STAT5 signaling pathway in oral squamous cell carcinoma.Mol Oncol. 2016 Jun;10(6):895-909. doi: 10.1016/j.molonc.2016.03.001. Epub 2016 Mar 22. Mol Oncol. 2016. PMID: 27038552 Free PMC article.
-
Cancer incidence among patients of the U.S. Veterans Affairs Health Care System.Mil Med. 2012 Jun;177(6):693-701. doi: 10.7205/milmed-d-11-00434. Mil Med. 2012. PMID: 22730846 Free PMC article.
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical